L vs TXG · P/E 14, rev $18.45B vs rev $610.8M
Loews Corp (L) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
Latest reported TXG revenue for 2024-12-31 was $610.8M. Net income was -$182.6M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. TXG currently screens at market cap $4.08B.
L currently screens at market cap $22.36B and trailing P/E 13.8. TXG currently screens at market cap $4.08B.
Not investment advice. Open the L and TXG stock pages for the full models.
Not investment advice.